Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
Iwamoto H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A.
Iwamoto H, et al. Among authors: kawaguchi s.
Biomedicines. 2022 Sep 22;10(10):2369. doi: 10.3390/biomedicines10102369.
Biomedicines. 2022.
PMID: 36289628
Free PMC article.